Loading...
Chemical structure of Aurora Kinase Inhibitor III

GC15711

Aurora Kinase Inhibitor III

Also known as N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide

Aurora Kinase Inhibitor III is a strong and selective Aurora A kinase inhibitor with an IC50 of 42 nM, and weakly inhibits EGFR with an IC50 of >10 μM

ChemicalCAS879127-16-9MW413.4FormulaC21H18F3N5O
CAS number
879127-16-9
Molecular weight
413.4
Formula
C21H18F3N5O
Solubility
≥ 18·32 mg/mL in DMSO with ultrasonic, ≥ 2·62 mg/mL in EtOH with ultrasonic and warming
InChIKey
RDTDWGQDFJPTPD-UHFFFAOYSA-N
Catalogue number
GC15711
Brand
GLPBIO
Computed properties PubChem CID 9549303 · XLogP 4.5 · TPSA 78.9 Ų · H-bond donors 3
XLogP
4.5
TPSA
78.9 Ų
H-bond donors
3
H-bond acceptors
8
Rotatable bonds
6
Heavy atoms
30

SMILES C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)NC4=CC=CC(=C4)C(F)(F)F

Computed descriptors from PubChem (CID 9549303), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.